Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.65 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.65 |
| ▸ | GMNN | O75496 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | THPO | P40225 | 1/20 | 0.65 |
| ▸ | MTOR | P42345 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | CETP | P11597 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | UBE2N | P61088 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3796385 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1964586 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL4287325 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL2312898 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL10571108 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL25243382 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL2233834 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL918858 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1964037 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL918041 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 437 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12539313-B2 | Microbial removal | CAPRETTO EHF. (IS) | 2026-02-03 | — | — | US | claimed |
| EP-4659733-A1 | BACTERICIDAL AND PRESERVATIVE COMPOSITION | Bjbiochem Co., Ltd. (KR) | 2025-12-10 | — | — | EP | claimed |
| EP-3934753-B1 | MICROBIAL REMOVAL | CAPRETTO EHF (IS) | 2025-11-05 | — | — | EP | claimed |
| US-12396941-B2 | Cosmetic composition that resists pilling | L'OREAL (FR) | 2025-08-26 | — | — | US | claimed |
| US-12303576-B2 | Two phase water-based smudge-resistant make-up remover | L'OREAL (FR) | 2025-05-20 | — | — | US | claimed |
| CN-119923268-A | Neem leaf extract | 劳伦茨·沃尔德维尔贝克 | 2025-05-02 | — | — | CN | claimed |
| WO-2024162523-A1 | BACTERICIDAL AND PRESERVATIVE COMPOSITION | 주식회사 비제이바이오켐 | 2024-08-08 | — | — | WO | claimed |
| WO-2024162594-A1 | BACTERICIDAL AND PRESERVATIVE COMPOSITION | 주식회사 비제이바이오켐 | 2024-08-08 | — | — | WO | claimed |
| US-20240245051-A1 | DISINFECTING, ANTIMICROBIAL AND PRESERVATIVE COMPOSITION | BJBIOCHEM CO., LTD. (KR) | 2024-07-25 | — | — | US | claimed |
| CN-118217453-A | Hyaluronic acid epidermis filling preparation and preparation method thereof | 湖南湘妃医疗器械有限公司 | 2024-06-21 | — | — | CN | claimed |
| EP-0507337-A2 | Novel erucyl, brassidyl and nervonyl derivatives | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1992-10-07 | — | — | EP | claimed |
| EP-0248062-B1 | MEDICAMENTS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1992-05-06 | — | — | EP | claimed |
| EP-0248047-B1 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1991-06-19 | — | — | EP | claimed |
| US-4837023-A | ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS | MAX-PLANCK-GESELLSCHAFT ZUR FOEDERUNG DER WISSENSCHAFTEN (DE) | 1989-06-06 | — | — | US | claimed |
| EP-0248047-A1 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE. | MAX PLANCK GESELLSCHAFT (DE) | 1987-12-09 | — | — | EP | claimed |
| EP-0248062-A1 | MEDICAMENTS. | MAX PLANCK GESELLSCHAFT (DE) | 1987-12-09 | — | — | EP | claimed |
| EP-0230575-A2 | Medicament active against tumours, containing hexadecylphosphocholine | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1987-08-05 | — | — | EP | claimed |
| WO-1987003480-A2 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSC (DE) | 1987-06-18 | — | — | WO | claimed |
| WO-1987003478-A2 | MEDICAMENTS | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSC (DE) | 1987-06-18 | — | — | WO | claimed |
| EP-0225608-A2 | Medicine | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1987-06-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539313-B2 | Microbial removal | CUTA, MIF, PCNA | LMNA 2232/4885CYP2D6 1344/4885SPHK1 2941/4885 |
| US-20240245051-A1 | DISINFECTING, ANTIMICROBIAL AND PRESERVATIVE COMPOSITION | CUTA, WASHC5, POLR1C | LMNA 2742/4885CYP2D6 1572/4885SPHK1 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.